tiprankstipranks
Trending News
More News >
Mosaic Co (MOS)
NYSE:MOS
US Market

Mosaic Co (MOS) Earnings Dates, Call Summary & Reports

Compare
1,975 Followers

Earnings Data

Report Date
May 06, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.31
Last Year’s EPS
0.49
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call conveyed a mixed but constructive outlook: significant operational and cost progress (production improvement, $150M cost savings achieved, Mosaic Biosciences growth, record and near-record production in key mines, portfolio monetizations) provide a strong platform for recovery. However, near-term headwinds are material — a large working capital drag ($960M), higher net debt, a pronounced sulfur-driven margin hit (~$250M EBITDA headwind to Q1), idled low-margin Brazil operations, and weaker U.S. phosphate demand in Q4. Management expects these issues to resolve progressively in 2026 (working capital release of $300M–$500M and production ramp), but the near-term cash/commodity cost pressures balance against the operational gains, producing a cautiously neutral stance.
Company Guidance
Mosaic guided to at least 7.0 million tonnes of phosphate production in 2026 (Q4’25 phosphate was 1.7 Mt) and roughly 9.0 million tonnes of potash (similar to 2025) while running potash at high operating rates and targeting record Esterhazy output; conversion costs improved to $112/tonne in Q4 for phosphate (goal sub-$100/tonne), potash cash cost averaged $75/tonne in 2025, and Mosaic Fertilizantes blended rock cost was $97/tonne. They expect CapEx around $1.5 billion in 2026 (stepping down toward ~$1.0 billion by 2030), ARO/environmental cash spending to decline by about $50 million in 2026 and to ~$200 million by 2030, and divestitures (including Carlsbad) to generate ~ $170 million of proceeds and reduce ARO by ~$60 million. Financially, Mosaic said working capital release of $300–$500 million is “highly possible” in 2026 (240k tonnes of excess phosphate ≈ $140 million near-term), Q1’26 faces an ~ $250 million EBITDA headwind from higher sulfur (each $10/tonne sulfur ≈ $10 million/quarter), 2025 WC drag was $960 million, net debt rose ~$829 million, EBITDA→CFO conversion fell to the mid-30s% in 2025 (versus a ~70% normalized target), and Mosaic Biosciences (net sales $68 million in 2025) expects another year of doubling with 8–10 new launches, 60+ registrations, sales in 16 countries and gross margins in the 40s.
Phosphate Production Recovery and 2026 Guidance
Produced 1.7 million tonnes of phosphate in Q4 2025 (despite an extended Bartow turnaround); company expects at least 7.0 million tonnes of phosphate production in 2026 with upside as operating factors normalize.
Potash Production Strength
International potash sales set a record in 2025; Esterhazy returned to full operating rates and HydroFloat is ramping. Mosaic expects to produce around 9 million tonnes of potash in 2026 (similar to 2025) and anticipates record Esterhazy output.
Material Cost and Efficiency Improvements
Delivered $150 million of cost savings in 2025 ahead of schedule and targets an additional $100 million of savings in 2026 through technology-enabled initiatives, supply chain optimization and supplier consolidation.
Improved Phosphate Conversion Cost
Fourth quarter phosphate cash cost of conversion was $112 per tonne — roughly $20 per tonne improvement from an earlier high watermark in 2025; management expects further structural declines with scale (targeting below $100 conversion cost over time).
Potash Cash Cost Competitiveness
Reported 2025 potash cash cost of production averaged $75 per tonne and would have met Analyst Day target range if not for higher-cost Colonsay extension.
Brazil Operations and Rock Cost Progress
Brazil rock output reached near-record levels in 2025; Mosaic Fertilizantes blended rock cost per tonne fell to $97 (lowest since 2021). Completed a 1 million tonne blending facility in Palmeirante to expand distribution capacity.
Mosaic Biosciences Rapid Growth
Mosaic Biosciences doubled net sales to $68 million in 2025, reached 60+ registrations and sales in 16 countries; management expects another year of doubling net sales in 2026 with 8–10 new product launches, and gross margins in the 40s.
Portfolio Reallocation and Monetization Progress
Divested several noncore assets (Patos de Minas, Taquari) and a pending Carlsbad sale; transactions announced in 2025 expected to generate approximately $170 million in proceeds and reduce ARO by ~$60 million. Ma'aden equity position valued at about $2.1 billion.
Working Capital Release Potential
Management estimates a $300 million to $500 million working capital release in 2026 driven by inventory drawdown (including ~240,000 tonnes excess phosphate rock, ~ $140 million at current values) and demand recovery, which should materially improve cash flow.
Capital Expenditure Path and Near-Term Investment
2026 CapEx expected around $1.5 billion (higher than 2025 due to gyp stack and clay settling area projects); management views this as a near-term peak and expects CapEx to trend down toward ~$1.0 billion by 2030.

Mosaic Co (MOS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MOS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 2026
2026 (Q1)
0.31 / -
0.49
Feb 24, 2026
2025 (Q4)
0.49 / 0.22
0.45-51.11% (-0.23)
Nov 04, 2025
2025 (Q3)
0.97 / 1.04
0.34205.88% (+0.70)
Aug 05, 2025
2025 (Q2)
0.73 / 0.51
0.54-5.56% (-0.03)
May 06, 2025
2025 (Q1)
0.45 / 0.49
0.65-24.62% (-0.16)
Feb 27, 2025
2024 (Q4)
0.57 / 0.45
0.71-36.62% (-0.26)
Nov 12, 2024
2024 (Q3)
0.52 / 0.34
0.68-50.00% (-0.34)
Aug 06, 2024
2024 (Q2)
0.66 / 0.54
1.04-48.08% (-0.50)
May 01, 2024
2024 (Q1)
0.66 / 0.65
1.14-42.98% (-0.49)
Feb 21, 2024
2023 (Q4)
0.87 / 0.71
1.74-59.20% (-1.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MOS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2026
$28.49$26.98-5.30%
Nov 04, 2025
$26.31$25.98-1.24%
Aug 05, 2025
$35.12$30.44-13.31%
May 06, 2025
$29.79$30.88+3.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Mosaic Co (MOS) report earnings?
Mosaic Co (MOS) is schdueled to report earning on May 06, 2026, After Close (Confirmed).
    What is Mosaic Co (MOS) earnings time?
    Mosaic Co (MOS) earnings time is at May 06, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MOS EPS forecast?
          MOS EPS forecast for the fiscal quarter 2026 (Q1) is 0.31.

            Mosaic Co (MOS) Earnings News

            Mosaic Company Can Benefit from High-Yielding Crops
            Premium
            Stock Analysis & Ideas
            Mosaic Company Can Benefit from High-Yielding Crops
            4y ago